Arboretum Ventures
Edit

Arboretum Ventures

https://www.arboretumvc.com
Last activity: 01.07.2024
Active
Arboretum Ventures is a venture capital firm specializing in the healthcare sector. Headquartered in Ann Arbor, Arboretum invests throughout the United States, but with a preference for Midwest opportunities. Our team targets capital efficient companies that can meaningfully reduce healthcare costs in our areas of expertise: devices, diagnostics, services, and IT.
Portfolio
4
Mentions
60
Location: United States, Michigan, Ann Arbor
Employees: 11-50
Founded date: 2002
Investment Type: Venture Capital

Portfolio 4

DateNameWebsiteTotal RaisedLocation
24.04.2023Convergent...convergentdental.com$98MUnited Sta...
06.01.2023Cardiac Di...cardiacdimensions.com$218.5MUnited Sta...
16.09.2021Allay Ther...allaytx.com$60MUnited Sta...
25.07.2005HealthMedi...healthmedia.com$2MUnited Sta...

Mentions in press and media 60

DateTitleDescription
01.07.2024RareCyte: $20 Million Raised To Expand Orion Spatial Biology PlatformRareCyte, a life sciences company offering advanced Precision Biology platforms, including instruments, reagents, software, and services, announced the completion of $20 million in funding from new and existing investors. New investor Fores...
23.02.2024Reprieve Cardiovascular Revolutionizes Heart Failure Treatment with $42M FundingReprieve Cardiovascular, a Milford, MA-based company, secures $42M in Series A funding to advance intelligent fluid management for heart failure patients. Led by Lightstone Ventures and Sante Ventures, the funding will propel Reprieve's mis...
22.02.2024Reprieve Cardiovascular Nabs $42M to Expand Intelligent Fluid Management for Heart FailureWhat You Should Know: – Reprieve Cardiovascular, a pioneer in personalized fluid management for acute decompensated heart failure (ADHF) emerges from stealth launching with $42M in Series A financing round. – The Series A round was co-led b...
26.01.2024Motif Neurotech Raises $18.75M for Implantable Device for Treatment-Resistant DepressionWhat You Should Know: – Motif Neurotech, a pioneer in minimally-invasive bioelectronics for mental health, announced today an impressive $18.75 million Series A funding round. Led by Arboretum Ventures, the investment saw participation from...
28.06.2023Arboretum Ventures Raises $268 Million, Aiming to Lower Healthcare CostsArboretum Ventures, a healthcare-focused venture-capital firm, has raised a $268 million fund to target startups with the goal of lowering costs for patients. The new fund in the health-tech sector is the latest example of how venture capit...
26.04.2021The winners of INVEST Pitch Perfect are…..The INVEST Pitch Perfect contest at the INVEST conference April 19-23 cast a spotlight on healthcare startups across biopharma, diagnostics, health IT, health services and medical devices. Judges scored the finalists from each track based o...
12.01.2021Baird Capital Invests in Jumpcode GenomicsBaird Capital announced today that its venture team has completed an investment in Jumpcode Genomics ("Jumpcode"), a genome technology company focused on improving the understanding of human disease. Joining Baird Capital in the $...
19.06.2019Slack’s Direct Listing, Libra Reactions, and Softbank Investment Projections: Term SheetSLACKIN’ Slack is about to hit the public markets on Thursday via a direct listing, and all eyes are on the company. Paid Content You can't secure what you can't see From ExtraHop As a reminder, direct listings are a considerably cheaper me...
01.04.2019UM Spinout Fifth Eye Lands $11.5M for Early Warning Patient Deterioration System for HospitalsFifth Eye, a medical device software spinoff from the University of Michigan building clinical early warning patient deterioration system for hospitals has raised $11.5 million in Series A funding led by Arboretum Ventures and Cultivation C...
26.04.2018Cardiac Dimensions Announces $39 Million Series B Financing for Innovative Device to Treat Patients With Heart FailureKIRKLAND, Wash.–(BUSINESS WIRE)– Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for patients with heart failure, today announced the company has closed a $39 million Series B financing. The roun...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In